Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.
Hansoh Pharmaceutical Group Company Limited Informations sur les dividendes
Hansoh Pharmaceutical Group Company Limited a un dividende annuel de 0.00 par action, avec un rendement de 0.00%. Le dividende est payé semestriellement et la dernière date d'ex-dividende était le Sep 22, 2025.
Rendement en dividend
Dividende annuel
Date ex-dividende
0.00%
$0.00
Sep 22, 2025
Fréquence des paiements
Taux de distribution
Semestriellement
0.00%
Historique des dividendes
Date ex-dividende
Montant en espèces
Date de registre
Date de paiement
Sep 22, 2025
$0.2316
Sep 25, 2025
Oct 30, 2025
Jul 3, 2025
$0.1353
Jul 4, 2025
Jul 25, 2025
Sep 20, 2024
$0.201
Sep 23, 2024
Oct 30, 2024
Jun 19, 2024
$0.1422
Jun 20, 2024
Jul 17, 2024
Sep 15, 2023
$0.0707
Sep 18, 2023
Sep 28, 2023
Jun 5, 2023
$0.05
Jun 6, 2023
Jul 5, 2023
Graphiques des dividendes
3692.HK Dividendes
3692.HK Croissance des dividendes (variation annuelle)
Follow-Up Questions
Quel est le dividende actuel payé par Hansoh Pharmaceutical Group Company Limited et son dividende annuel ?
Quel est le ratio de distribution de dividendes de Hansoh Pharmaceutical Group Company Limited ?
Quelle est la date ex-dividende pour 3692.HK ?
À quelle fréquence Hansoh Pharmaceutical Group Company Limited verse-t-elle des dividendes ?